Introduction
Alexander disease is a progressive rare and usually fatal devastating disorder of the central nervous system 1 characterized by demyelination of the white matter 2 and by the presence of Rosenthal fibers, containing glial fibrillary acidic protein (GFAP), aB-crystallin and heatshock protein 27. 3 Alexander disease manifests with different clinical and pathological signs, mainly depending on the age of onset of the disease. In particular, infantile, juvenile and adult forms can be distinguished on the basis of increasing age of onset, which correlates with progressively less severe phenotypes of the disease. 4 While the infantile form is characterized by motor and mental retardation, bulbar dysfunction, seizures and megalencephaly due to a marked defect in myelination in the frontal lobes, juvenile and adult forms show difficulties of coordination, speech and swallowing without myelin and mental function defects. 4 The three forms, although characterized by a wide phenotypic heterogeneity, are all associated with heterozygous amino-acid changes in the GFAP gene, encoding the homonymous astrocyte-specific protein belonging to the type III intermediate filament (IF) family. 5 Although the vast majority of nucleotide changes seems clustered in specific codons of exons 1, 4, and 8, 6 protein domains 1A, 1B, 2A and 2B, characterized by a-helical structures, are frequently defective. Functional studies have shown cytoplasmic inclusions similar to Rosenthal fibers in murine astrocytes and in several cell lines overexpressing wild-type (wt) GFAP, suggesting that formation of GFAP aggregates could be due to elevated production of the protein. 7, 8 More recently, studies have been focused on the effect induced by the most frequent mutations, associated with the severe infantile phenotype, p.R239C and p.R239H. In particular, it has been shown that the p.R239C substitution can prevent formation of a regular filamentous pattern, alter the normal solubility of the protein in several cell lines and impair the wt GFAP organization. 9 -11 Moreover, as the accumulation of p.R239C GFAP seems to lead to a decrease of proteasome activity, this latter proteasomal hypofunction likely cooperates to produce further GFAP accumulation and cellular stress responses, thus inducing a continuous raising in the aggregation rate. 11 Finally, a more recent work has provided evidence for a link between the extent of GFAP functional alteration and the domain where mutations are located.
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In this paper, we report the first functional study aimed at clarifying the effects of the novel c.[988C4G; 994G4A] complex allele, leading to p.[R330G; E332K], detected in four members of a family affected with adult-onset Alexander disease. In particular, we suggest that the observed differences between effects due to the p.[R330G; E332K] and p.R239C mutations, in terms of both severity of GFAP aggregation rate and rescue of the correct filament organization consequent to indirect aB-crystallin overexpression, account for the different clinical severity of the two associated Alexander forms.
Materials and methods

Family
Clinical and radiological features of four members of a family carrying the novel c.[988C4G; 994G4A] complex allele, leading to p.[R330G; E332K], and affected with adult-onset Alexander disease, have already been reported. 13 Blood samples of the proband (onset: 56 years) and the other members were obtained with informed consent. Genomic DNA was extracted using standard procedures.
GFAP expression plasmid construction
Human wt GFAP-GFP expression construct Total RNA was extracted from U251-MG human astrocytoma cell line (RNeasy Mini Kit, Qiagen). GFAP cDNA (GeneBank accession no. S40719) lacking the stop codon was prepared from 1 mg of total RNA (Advantage RT-for-PCR kit) and amplified with the forward primer, containing the underlined EcoRI cleavage site, GFAP -EcoRI(F) 5 0 -AAATGAATTCGAGCCA GAGCAGGATGGAG-3 0 and the reverse primer, containing the underlined SacII cleavage site, GFAP-SacII(R) 5 0 -CA ACCCGCGGCATCACATCCTTGTGCTCCTG-3 0 . The PCR product was cloned upstream of the GFP cDNA in the pcDNA3.1/CT-GFP-TOPO vector (Invitrogen), thus allowing for a wt GFAP-GFP fusion product characterized by the 3 0 end of the GFAP protein in frame with the 5 0 end of the GFP protein. Such a hybrid construct was completely sequenced using a Big Dye Terminator cycle sequencing kit (Applied Biosystem) on an ABI 3100 DNA automated Sequencer.
Mutated GFAP-GFP expression constructs GFAP missense mutations were generated through site-specific mutagenesis using the wt cDNA plasmid as a template. In particular, primers GFAP -
were used for p.[R330G; E332K]-GFP. All PCR products were completely sequenced with both plasmid-and GFAP-specific primers.
Far-red fluorescence wt GFAP The fragment containing the wt GFAP cDNA was EcoRI -SacII double digested from the pcDNA3.1/CT-GFP-TOPO[wild-type GFAP] construct and inserted upstream the HcRed cDNA into the pHcRed1-N1 vector (Clontech) after EcoRI -SacII digestion.
Cell culture and transient transfections U251-MG human astrocytoma cell line was grown in RPMI medium (Euroclone) supplemented with 10% FBS (New Zealand), 1% L-glutamine (100 Â ), 100 U/ml penicillin and 100 mg/ml streptomycin in a humidified atmosphere with 5% CO 2 Immunocytochemistry Forty-eight hours after transfection with the GFP-fused expression constructs, U251-MG cells were prepared as already described. 14 Plates were then incubated with a TRITC-conjugated vimentin-or ubiquitin-specific antibody (Santa Cruz Biotechnology) for 60 -90 min and, after washing with PBS, were analyzed with a Zeiss Axiophot fluorescence microscope.
Analysis of aB-crystallin expression U251-MG cells were plated in 60 mm dishes and, after 24 h, added with 10 or 60 mM potassium chloride (KCl). 15 Fortyeight hours later, total RNA was extracted (RNeasy Mini kit, Qiagen) and cDNA (GeneBank accession no. NM_001885) was reverse transcribed from 1 mg of total RNA (Advantage RT-for-PCR Kit, Clontech). A 545 bp fragment containing the full-length aB-crystallin coding region was amplified with the forward primer aB-cryst(F) 5 0 -AATTAAGCTTATG GACATCGCCATCCACCAC-3 0 and the reverse primer aBcryst(R) 5 0 -AATTGGTACCTTTCTTGGGGGCTGCGGTGA-3 0 . In addition, evaluation of the housekeeping gene G3PDH was performed in the same samples, by using oligonucleotides provided in the Advantage RT-for-PCR Kit and following manufacturer's instruction.
Results
Genetic and clinical features of a family with recurrent adult-onset Alexander disease
In four different members of an Italian family, characterized by recurrent adult-onset Alexander disease, we have identified two novel missense mutations c.988C4G and c.994G4A on a same GFAP allele, leading to substitutions p.R330G and p.E332K, respectively. Both mutations were present in the proband (onset: 56 years), in his son (onset: 28 years), and in his two sisters (onset: 53 years; presymptomatic) 13 ( Figure 1a ). Whereas pseudo-bulbar signs were present in all symptomatic members, the youngest patient had developed neither spasticity nor ataxia, yet.
In vitro organization of GFAP filaments Altered solubility and disrupted conformation, due to a break in the a-helix stretch, could be predicted for the p. Figure 1c ). In addition, transfection of constructs encoding for the single mutant alleles has revealed that, in agreement with in silico analysis, the p.R330G and p.E332K changes did not separately induce a cellular phenotype more severe than the p.[R330G; E332K] complex mutation.
In particular, the proportion of cells with a filamentous organization induced by the p.R330G construct was not significantly different from that observed in cells transfected with the wt GFAP, suggesting that the p.R330G change alone does not have any significant effect. On the other hand, p.E332K induced an uncorrected GFAP pattern in a fraction of cells not statistically different from that expressing the complex allele, thus suggesting that the effects shown by this latter are likely due to the presence of the p.E332K mutation rather than of the p.R330G mutation (Figure 1c) .
Analysis of GFAP protein expression
As overexpression of the wild-type protein has been shown to induce aggregation in murine astrocytes per se, 7 and aggregation of mutant GFAP has been shown to induce inhibition of the proteasome activity with consequent raising in protein levels, 11 we have investigated whether the amount of aggregates in cells expressing the p.[R330G; E332K] GFAP could be associated with enhanced levels of the mutant protein.
First, we have assessed the involvement of the ubiquitinproteasome system (UPS) in the degradation of mutant GFAP by observing both colocalization of ubiquitin in GFAP aggregates (Figure 2a ) and a statistically significant increase in the percentage of cells containing a mutant GFAP exclusive aggregate pattern, consequent to treatment with the proteasome inhibitor lactacystin (Figure 2b) . However, the comparison of mutant protein levels with the amount of wt GFAP has not shown any difference for the p.[R330G; E332K] mutant protein, while, as expected on the basis of the previous observations, 11 it has shown a significant increase for the p.R239C protein (Figure 2c) . One-way analysis of variance, performed on the proportions of the filamentous pattern among the five groups, resulted highly significant (Po0.005) and prompted us to pair-wise comparisons using the Student's t-test. Statistical differences of the filamentous pattern (black bars) with respect to the wild-type distribution are indicated by asterisks (*Po0.05; **Po0.01).
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shown), morphological analysis in cells characterized by expression of both plasmids was performed. As shown in Figure 3a , in most cells green and red fluorescence showed colocalization. Moreover, in comparison with cells expressing only the wt GFAP-HcRed protein, coexpression of wt and p.[R330G; E332K]-GFP mutant caused a 30% decrease in cells presenting a wild-type filamentous structure (not shown), suggesting that the wt GFAP was entrapped into mutant protein inclusions, and therefore the occurrence of dominant effects of the mutant protein. Moreover, as GFAP can polymerize either on its own or with vimentin, we wondered whether the formation of GFAP aggregates due to forced expression of the mutant protein could disrupt the endogenous vimentin filamentous pattern. U251-MG cells, expressing endogenous vimentin, were stained with a TRITC-conjugated vimentin-specific antibody 48 h after transfection with the p.[R330G; E332K]-GFP expression construct. As reported in Figure 3b , two different GFAPvimentin IF networks could be observed. In line I, a cytoskeletal pattern of p.[R330G; E332K]-GFP GFAP, characterized by numerous small aggregates placed on a filamentous network, is shown; in this case, observed in 80% cells, vimentin filaments display a normal spread organization without any dislocation or association with GFAP inclusions. On the other hand, line II shows a cell in which mutant GFAP organizes in a thick perinuclear pattern, disrupting the endogenous vimentin network by causing filaments to collapse around the nucleus; this latter was the rarest pattern among those observed, suggesting that disruption of IF cytoskeleton is not the main pathogenic mechanism of this mutation.
Rescue of wt GFAP phenotype consequent to KCl treatment Recent studies have shown that the heat-shock protein aB-crystallin accumulates in Rosenthal fibers of patients with Alexander disease 18 and that its overexpression induces disaggregation of human GFAP inclusions. 8 Because of the low U251-MG cells transfection efficiency, to investigate the aB-crystallin effect on inclusions due to the p.[R330G; E332K] GFAP mutation, we decided to upregulate aB-crystallin indirectly, by the addition of KCl in the extracellular medium, rather than cotransfecting an aB-crystallin expression construct. 15, 18 First, to confirm that our cellular system was responsive to KCl treatments, U251-MG cells were exposed to either 10 or 60 mM KCl for 24 h and analyzed for the aB-crystallin expression. As reported in Figure 4a complete recovery of the wild-type phenotype in this cellular system ( Figure 4b) ; although we observed a significant ability of p.R239C-transfected cells to rescue a filamentous pattern, the wild-type phenotype could not be achieved in this mutant. Finally, FACS analysis has shown no differences in mutant GFAP protein levels in cells grown with or without KCl treatment, thus excluding that our observations may be due to enhanced elimination of the misfolded protein (data not shown).
Discussion
In the present paper, we report a functional study aimed at elucidating the pathogenic effect of the co-occurrence of two mutations detected on a same GFAP allele, leading to p.[R330G; E332K], in four members of a family with recurrence of an adult form of Alexander disease.
To directly test the effect of the double amino-acid change, suggested by in silico analysis to induce protein conformational changes, cytoskeletal structures assembled by wt GFAP and mutant GFAP were visualized in transient transfections of human astrocytoma U251-MG cells. Overexpression of wt GFAP has been observed to induce development of cytoplasmic inclusions similar to Rosenthal fibers in mouse astrocytes 7 and formation of aggregated structures in several cellular models. Among these, the human astrocytoma U251-MG cells have been reported to show a very low proportion of wt GFAP-transfected cells containing inclusions, 8, 11 thus suggesting that they might be used as a suitable cell model to test our hypothesis. Transient transfections in U251-MG cells have shown that cells characterized by aggregation of the p.[R330G; E332K] protein are significantly fewer than those containing p.R239C-induced aggregates. In addition, transfections of the single mutant proteins have suggested that the p.R330G alone does not have any effect, while the p.E332K seems to induce an uncorrected GFAP pattern in a significant fraction of cells, likely reflecting a major role played by this latter change in the complex alleleassociated pathogenesis.
Moreover, the recent identification of the p.E332K substitution in another Italian patient affected with the adult-onset form of Alexander disease has confirmed the pathogenic role of this mutation when acting alone (DP, manuscript in preparation). In particular, this 61-year-old patient had a 4-year history of progressive limb weakness, followed by dysphonia due to vocal cord palsy and dysphagia. On examination, he also showed nystagmus, mild ataxia, pyramidal signs, and limb girdle wasting and weakness. Brain and cervical spinal cord radiological findings were consistent with those previously described in adult-onset Alexander disease with GFAP mutations. 19 Therefore, clinical observation and experimental results suggest to exclude a synergistic as well as a complementation effect of the two mutations within the complex allele, suggesting in addition that the p.E332K, and not the p.R330G, does contribute to the observed effects. Recently, a positive feedback loop between GFAP accumulation and proteasome activity inhibition, mediated by activation of the MLK -JNK pathway, has been shown to sustain GFAP protein accumulation and aggregation. 11 We have confirmed the involvement of the UPS in the cell response to the p. 
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The interference of the mutant protein with wild-type correct polymerization, suggested by the observed drastic decrease of cells presenting a wt GFAP filamentous pattern in the presence of the p.[R330G; E332K] mutant protein, may be considered as an additional disease-causing mechanism induced by our mutation. This is in accordance with the reduced amount of cells presenting a GFAP regular pattern consequent to coexpression of wt GFAP and p.R239C mutant GFAP in SW13vimÀ cells, 10 However, the very few interference of the p.[R330G; E332K] mutant in vimentin filaments organization is a further evidence that this GFAP mutation is not so deleterious.
We then wondered whether and how much aB-crystallin overexpression could induce the rescue of the filamentous pattern in cells expressing either the mild p.[R330G; E332K] or the severe p.239C alleles, a circumstance likely to further account for the differences observed in the disease severity associated with the two mutations. KCl has been used to induce aB-crystallin overexpression, although we cannot exclude additional effects of such a treatment on neurofilament organization and/or aggregate formation. In any case, treatment of cells with 10 mM KCl was sufficient to have a complete rescue of the correct GFAP filamentous phenotype in cells expressing the mild mutant, while a correct filamentous pattern was not completely achieved in cells expressing the severe allele at any KCl dose tested. The inefficacy in preventing aggregate formation observed by coexpressing aB-crystallin and murine p.R236H GFAP 20 does not seem in accordance with results obtained by us for the mild mutant. However, we believe that the partial rescue we achieved with the p.R239C mutant, equivalent to the murine p.R236H, can be explained by results observed by Mignot et al, 20 thus
suggesting that severe GFAP mutations are more refractory than mild mutations to the cellular refolding mechanisms. All these in vitro observations have shown less severe effects for the adult-onset-associated mutation in comparison with those observed for the p.R239C mutant, thus accounting for the different clinical and MRI features observed in association with the different Alexander disease forms.
In silico analysis of residue conservation in IFs has shown that the E332 residues lies within a sequence that shows a low degree of homology with other type III IFs. In particular, the observation that the E332 residue is present only in desmin and nestin seems to account for the not deleterious effect induced by the substitution.
The hypothesis that the mild effect of the novel allele could be due to its peculiar location is strengthened by our recent identification of the p.E332K mutation in an isolated case of adult Alexander disease (unpublished data) and by a recent report of a family characterized by dominantly inherited asymptomatic Alexander disease due to the missense substitution p.L331P, 21 suggesting that genetic anomalies in this region are likely associated with a mild disease phenotype.
